Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00762177 · ClinicalTrials.gov registry record · Phase 3
Investigate Oral Bacteria in Adult Population
A Phase 3 study, sponsored by Colgate Palmolive.
- Completed
- Registry status
- Phase 3
- Development phase
- 24
- Enrollment target
NCT00762177: Completed Phase 3 study, sponsored by Colgate Palmolive.
NCT00762177 is a Phase 3 study that has completed, run by Colgate Palmolive. The registered enrollment target is 24 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00762177, a Phase 3 study, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 24 participants
- Enrollment target
Study Summary
To compare the antimicrobial efficacy of three dentifrices on oral bacteria
Primary Outcome
After 14 days of study product use, dental plaque was scraped from the subject's teeth. The plaque was placed in sterile phosphate buffered saline(PBS) and sonicated using a Branson 450A sonicator with a cup horn for 30 seconds. Samples diluted (10 fold) in PBS and plated using a spiral systems autoplate 4000 spiral plater on CFAT Agar
Interventions
- DRUG Stannous Fluoride
- DRUG Fluoride
- DRUG Fluoride, Triclosan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-05 |
| Est. Completion | 2008-09 |
| Phase | Phase 3 |
What the finished NCT00762177 record still lists
NCT00762177 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 3 interventions - of which Stannous Fluoride is the first listed.
NCT00762177 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00762177 about?
NCT00762177 is a clinical study titled "Investigate Oral Bacteria in Adult Population". To compare the antimicrobial efficacy of three dentifrices on oral bacteria
What is the current status of trial NCT00762177?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 24 participants. The study started on 2008-05. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00762177?
The interventions under investigation include: Stannous Fluoride (DRUG), Fluoride (DRUG), Fluoride, Triclosan (DRUG).
Who is sponsoring clinical trial NCT00762177?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00762177's enrollment target sits among peer trials
24 1943rd of 2000 higher than 49 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia